Saltar al contenido
Merck
  • Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate.

Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate.

Organic letters (2014-06-24)
Atsushi Nakayama, Akinori Okano, Yiqing Feng, James C Collins, Karen C Collins, Christopher T Walsh, Dale L Boger
RESUMEN

Studies on the further development of the sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and the observation of unusual, perhaps unexpected, aglycon substrate substituent effects on the rate and efficiency of the initial glycosylation reaction are reported.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Vancomicina hydrochloride from Streptomyces orientalis, ≥900 μg per mg (as vancomycin base)
Sigma-Aldrich
Vancomicina hydrochloride from Streptomyces orientalis, ≥85% (Vancomycin B)
Sigma-Aldrich
Vancomicina hydrochloride from Streptomyces orientalis, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Vancomicina hydrochloride from Streptomyces orientalis, meets USP testing specifications
Sigma-Aldrich
Phosphorylase b from rabbit muscle, lyophilized powder, ≥20 units/mg protein, 2× crystallization
Millipore
Vancomycin supplement, suitable for microbiology
Vancomycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Phosphorylase b from rabbit muscle, For use as a marker in SDS-PAGE